Last update:
Neuroscience
NMDARs (N-methyl-D-aspartate receptors) serve as valves on nerve cells, controlling the flow of electrical signals in the brain. This special group of receptors is suspect in many neurological diseases, including Alzheimer's, ...
Jan 22, 2020
0
76
Parkinson's & Movement disorders
Scientists have discovered that a non-invasive technique which could one day be used to treat Parkinson's disease, can successfully target a highly specific group of brain cells which play a key role in development of the ...
Jan 22, 2020
0
89
Research by University at Buffalo biologists is providing new insights into alpha-synuclein, a small acidic protein associated with Parkinson's disease.
Jan 16, 2020
0
101
The International Parkinson Disease Genomics Consortium (IPDGC) has now been in existence for ten years. In an article published in the Journal of Parkinson's Disease the consortium reviews the progress made over the past ...
Jan 16, 2020
0
4
A common bacteria that boosts digestive health can slow—and even reverse—build-up of a protein associated with Parkinson's, new research suggests.
Jan 14, 2020
4
1255
A synthetic small molecule compound called AQAMAN can prevent and even reverse harmful protein build-up in neurons that is associated with several rare neurodegenerative disorders, including polyglutamine (or polyQ) diseases.
Jan 10, 2020
1
18
As many as seven to 10 million people in the world are thought to live with Parkinson's disease (PD). Being the second most common neurodegenerative disease, PD severely affects patients' quality of life, not just brining ...
Jan 09, 2020
0
93
Parkinson's disease is a neurodegenerative disorder that manifests through symptoms such as tremor, slow movements, limb rigidity and gait and balance problems. As such, nearly all diagnostic testing revolves around how a ...
Dec 27, 2019
0
15
A drug that provides the benefits obtained from medicinal cannabis without the "high" or other side effects may help to unlock a new treatment for Parkinson's disease.
Dec 19, 2019
0
58
Parkinson's patients' motor and non-motor symptoms were improved with a weekly exercise regimen that included physical and cognitive tasks, according to new research presented today (18 December) at The Physiological Society ...
Dec 18, 2019
0
1
Neurodegenerative diseases such as Alzheimer's and Parkinson's can be devastating to patients and their families. These diseases are difficult to diagnose before symptoms show, meaning it's often already too late to reverse ...
Dec 17, 2019
0
8
A clinical trial investigating the repurposed cancer drug nilotinib in people with Parkinson's disease finds that it is reasonably safe and well tolerated. Researchers also report finding an increase in dopamine, the chemical ...
Dec 16, 2019
0
1
Northwestern University and the Parkinson Study Group announced that the Nilotinib in Parkinson's Disease (NILO-PD) study showed that nilotinib, an FDA-approved treatment for chronic myelogenous leukemia being tested for ...
Dec 05, 2019
0
15
Parkinson's and multisystem atrophy (MSA), both neurodegenerative diseases, are associated with the accumulation of alpha-synuclein proteins in the brain. Researchers at the German Center for Neurodegenerative Diseases (DZNE) ...
Dec 05, 2019
0
26
Chaperone proteins in human cells dynamically interact with the protein α-Synuclein, which is strongly associated with Parkinson's disease. A disturbed relationship to these "bodyguards" leads to cell damage and the formation ...
Dec 04, 2019
0
59
A new University of Toronto study sheds light on how protein strains vary in the brains of those affected by progressive neurodegenerative diseases like Parkinson's, suggesting the need for patient-specific medicines.
Dec 04, 2019
0
54
All neurodegenerative diseases have a common thread: the appearance of protein clumps in the brain such as amyloid-beta plaques in Alzheimer's disease and alpha synuclein aggregates in Parkinson's. The root cause of this ...
Dec 03, 2019
1
404
Researchers have identified nine cases of people who lost their ability to swim after having a deep brain stimulation device implanted to control symptoms of Parkinson's disease. The new research is published in the November ...
Nov 27, 2019
0
26
Screening technology to catch Parkinson's disease in its earliest stages could be available within three years, following an agreement between RMIT University and start-up company Jesse Medical.
Nov 27, 2019
0
3
A procedure that applies pulses of focused ultrasound to the brain is safe and effective for reducing tremors and improving quality of life in people with essential tremor (ET) or Parkinson's disease (PD) tremor, according ...
Nov 26, 2019
0
6
21 hours ago
Jan 25, 2020
Jan 25, 2020
Jan 25, 2020
